Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP vs. Fractionated ICED in Untreated PTCL
NCT02445404Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Sep 2015
- Primary completion
- Jun 2022
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ifosfamide, carboplatin, etoposide, dexamethasone in peripheral T-cell lymphoma (PTCL), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
ifosfamidecarboplatinetoposidedexamethasone
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02445404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445404.